Mechanisms of Obesity-Induced Gastrointestinal Neoplasia

Slides:



Advertisements
Similar presentations
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Advertisements

NUTRITION AND CANCER: BEFORE, DURING AND AFTER Andrew D. Nish MD.
Primary Prevention of Colorectal Cancer
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Covering the Cover Gastroenterology
Obesity and Cancer: The Oil that Feeds the Flame
Laura A. Smith, MPH, RD, Ciara H. O’Flanagan, PhD, Laura W
Primary Prevention of Colorectal Cancer
Inflammation and Colon Cancer
Aspirin use and endometrial cancer risk and survival
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Obesity Heats Up Adipose Tissue Lymphocytes
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Covering the Cover Gastroenterology
Diet, Obesity, and Chronic Disease
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Volume 145, Issue 4, Pages (October 2013)
NAFLD, Obesity, and Bariatric Surgery
Racial Disparity in Gastrointestinal Cancer Risk
Minoti V. Apte, Jeremy S. Wilson, Aurelia Lugea, Stephen J. Pandol 
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Roles for Chemokines in Liver Disease
Mesenchymal Cells in Colon Cancer
Making Sense of HDAC2 Mutations in Colon Cancer
Identifying and Treating COPD in Cardiac Patients
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Fishing Out a Sensor for Anti-inflammatory Oils
Eva Wertheimer, Marcelo G. Kazanietz  Gastroenterology 
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Volume 155, Issue 4, Pages (October 2018)
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer  Ilya Gukovsky, Ning Li, Jelena Todoric,
The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas  Edward Giovannucci, Dominique Michaud  Gastroenterology 
Intestinal Inflammation and Cancer
Volume 141, Issue 1, Pages (July 2011)
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Volume 137, Issue 1, Pages (July 2009)
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 146, Issue 5, Pages (May 2014)
Obesity, Inflammation, and Insulin Resistance
Host Immune Response to Infection and Cancer: Unexpected Commonalities
IKKɛ: A Bridge between Obesity and Inflammation
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
John T. Chang, William J. Sandborn  Gastroenterology 
Bridging immunity and lipid metabolism by gut microbiota
Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
An Integrated View of Immunometabolism
Microbes, Microbiota, and Colon Cancer
Coffee and Colorectal Cancer: Grounds for Prevention?
Volume 150, Issue 5, Pages (May 2016)
Frances Balkwill, Kellie A. Charles, Alberto Mantovani  Cancer Cell 
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Fishing Out a Sensor for Anti-inflammatory Oils
Subhra K. Biswas, Raffaella Bonecchi  Cell Metabolism 
The Gastrointestinal Tumor Microenvironment
Volume 145, Issue 6, Pages e5 (December 2013)
A New “Immunological” Role for Adipocytes in Obesity
Volume 142, Issue 4, Pages e6 (April 2012)
Clinical Gastroenterology and Hepatology
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Volume 138, Issue 6, Pages (May 2010)
Macrophages, Immunity, and Metabolic Disease
Adipose tissue, adipokines, and inflammation
Volume 76, Issue 2, Pages (July 2009)
Volume 135, Issue 6, Pages (December 2008)
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Mechanisms of Obesity-Induced Gastrointestinal Neoplasia José O. Alemán, Leonardo H. Eusebi, Luigi Ricciardiello, Kavish Patidar, Arun J. Sanyal, Peter R. Holt  Gastroenterology  Volume 146, Issue 2, Pages 357-373 (February 2014) DOI: 10.1053/j.gastro.2013.11.051 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 RRs of GI cancers in obese men and women. Obesity confers an increased risk of several malignancies. Reductions in rates of obesity should result in a decreased incidence of cancer and potentially mortality. In men, obesity-associated cancers include esophageal, colon, liver, pancreas, and prostate. In women, obesity-associated cancers include endometrial, gallbladder, breast (postmenopausal women), pancreas and colon. Data are presented as RR per 5-kg/m2 increase in BMI. Adapted with permission from Renehan et al.3 Gastroenterology 2014 146, 357-373DOI: (10.1053/j.gastro.2013.11.051) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Inflammation and adipocytes. Interactions among circulating and local factors contribute to obesity-associated inflammation. Adipocytes are cells specialized for storage of nutrients in the form of triglyceride and cholesterol. Leptin and adiponectin are examples of adipokines produced in response to adipocyte size and overall energy balance. After reaching an undefined trigger (adipocyte size, hypoxia, insulin resistance), immune cells, including macrophages, are recruited to adipocytes. This activates an inflammatory response that leads to secretion of TNF-α, IL-6, PA-1, MCP-1, interferon gamma, and vascular endothelial growth factor. The resulting chronic inflammation leads to insulin resistance, cardiovascular disease, and different cancers. IFN, interferon; VEGF, vascular endothelial growth factor. Gastroenterology 2014 146, 357-373DOI: (10.1053/j.gastro.2013.11.051) Copyright © 2014 AGA Institute Terms and Conditions

Figure 3 Obesity-induced factors contribute to colorectal carcinogenesis. Mechanisms by which obesity could contribute to development of CRC are shown. Western-style diets lead to increased adiposity and changes in the microbiota to adapt to the increased energy supply. Adipokines such as leptin and adiponectin could allow for establishment of a tumor microenvironment. In obese subjects, hyperlipidemia and insulin resistance lead to low-grade systemic inflammation, which promotes tumor cell proliferation and angiogenesis and reduces apoptosis. These mechanisms are likely to vary among subjects, and little is known about their interactions. Gastroenterology 2014 146, 357-373DOI: (10.1053/j.gastro.2013.11.051) Copyright © 2014 AGA Institute Terms and Conditions

Figure 4 Obesity and esophageal cancer. Mechanisms by which obesity could contribute to carcinogenesis in the esophagus are shown. In early stages of obesity, leptin and adiponectin contribute to the frequency and development of BE. The transition from benign metaplasia to dysplasia is believed to be partially mediated by changes in the microbiota in addition to an acid environment. Development of aneuploidy and subsequent cancer have been associated with chronic low-grade inflammation and altered levels of IGF-I. It is not clear whether obesity contributes to metastasis of esophageal cancer. Gastroenterology 2014 146, 357-373DOI: (10.1053/j.gastro.2013.11.051) Copyright © 2014 AGA Institute Terms and Conditions